Schering-Plough Corporation

As of November 3, 2009, Schering-Plough Corporation was acquired by Merck & Co. Inc. Schering-Plough Corporation discovers, develops, manufactures, and sells pharmaceuticals worldwide. It operates in three segments: Prescription Pharmaceuticals, Animal Health, and Consumer Health Care. The Prescription Pharmaceuticals segment offers human pharmaceutical products in six therapeutic areas, including cardiovascular, central nervous system, immunology and infectious disease, oncology, respiratory, and women’s health. This segment sells its products through wholesale and specialty distributors, hospitals, managed care organizations, retail and specialty pharmacists, and government agencies. The Animal Health segment discovers, develops, manufactures, and markets animal health products, including vaccines. Its products include livestock products, poultry products, companion animal products, and aquaculture products. This segment offers its products to veterinarians, distributors, and animal producers. The Consumer Health Care segment manufactures and sells over-the-counter, foot care, and sun care products. This segment sells its products through wholesale and retail drug, food chain, and mass merchandiser outlets. The company has a collaboration agreement with Alder Biopharmaceuticals Inc. to identify therapeutic monoclonal antibody lead candidates for central nervous system disorders. Schering-Plough Corporation was founded in 1928 and is headquartered in Kenilworth, New Jersey.